Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Example in development - Triple agonists targeting GLP-1, GIP, and glucagon are in early trials
Bettermann EL, et al
Your doctor can provide guidance on managing these side effects and help determine the best course of action
The Finnish Diabetes Prevention Study reported similar findings
Self-pay patients (who dont have insurance that covers Ozempic) can get the medication at a reduced cash price
If these results confirm the Phase 2 findings, Retatrutide could become one of the few medications that simultaneously addresses obesity, cardiovascular risk, and liver disease in a single weekly injection
US$ 26.99
US$ 27.52
US$ 24.27
US$ 25.10
US$ 28.73
US$ 21.79
US$ 25.05
